Home > Insider Trading > Filing (0001209191-23-049366)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1782223	Pyxis Oncology Inc.	PYXS	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1769457	Lara Sullivan	C/O Pyxis Oncology, Inc. 321 Harrison Avenue Boston MA 02118	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2023-09-11	20,000	$2.27	2,605,182	No	4	S	Direct
Common Stock	Disposition	2023-09-12	4,917	$2.25	2,600,265	No	4	S	Direct
Common Stock	Disposition	2023-09-13	3,000	$2.27	2,597,265	No	4	S	Direct
Common Stock	Disposition	2023-09-13	184,742	$2.13	2,412,523	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	F	Direct

Footnotes

Reflects sales of common stock executed in multiple transactions. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected within the ranges set forth in footnotes 2 through 4 of this Form 4.
The transaction was executed in multiple trades in prices ranging from $2.13 to $2.36.
The transaction was executed in multiple trades in prices ranging from $2.21 to $2.30.
The transaction was executed in multiple trades in prices ranging from $2.25 to $2.34.
Represents shares withheld to cover taxes due upon the vesting of certain restricted stock units.